Animal Drug Compounding Market Size, Share, and Growth Report 2032
Animal Drug Compounding Market - By Product (Anti-Infectives, Anti-Inflammatory, GI Drugs, and CNS Agents), By Animal Type (Companion Animal and Livestock Animal), By Dosage Form (Capsule, Powder, Solution, and Suspension), By Route of Administration (Oral, Ocular, Injectables, Topical, and Rectal), And By Region- Global Industry Perspective, Comprehensive Analysis, and Forecast, 2024 - 2032
| Market Size in 2023 | Market Forecast in 2032 | CAGR (in %) | Base Year |
|---|---|---|---|
| USD 2.63 Billion | USD 5.82 Billion | 9.2% | 2023 |
Table Of Content
- Chapter 1.Preface
- 1.1.Report Description and Scope
- 1.2.Research Scope
- 1.3.Research Methodology
- 1.3.1.Market Research Type
- 1.3.2.Market Research Methodology
- Chapter 2.Executive Summary
- 2.1.Animal Drug Compounding Market, 2018–2028(USD Billion)
- 2.2.Animal Drug Compounding Market: Snapshot
- Chapter 3.Global Animal Drug CompoundingMarket– Industry Analysis
- 3.1.Animal Drug CompoundingMarket: Market Dynamics
- 3.2.Market Drivers
- 3.2.1. Safe & effective drugs are vital for veterinarians in treating animals & pets. Furthermore, a veterinarian medicine approved by U.S. FDA is not always accessible to veterinary physicians for treating pet animals and in these situations veterinarians apply compounded drugs for effectively treating animal conditions. Such moves will prop up expansion of animal drug compounding market.
- 3.2.2.Animal health sector supports use of animal drug compounds for addressing healthcare requirements of animals, thereby inflating animal drug compounding industry size.
- 3.3.Porter’s Five Forces Analysis
- 3.4.Market Attractiveness Analysis
- 3.4.1.Market attractiveness analysis By Product
- 3.4.2.Market attractiveness analysis By Animal Type
- 3.4.3.Market attractiveness analysis By Route of Administration
- 3.4.4.Market attractiveness analysis By Dosage Form
- Chapter 4.Global Animal Drug CompoundingMarket– Competitive Landscape
- 4.1.Company market share analysis
- 4.1.1.Global Animal Drug CompoundingMarket: company market share, 2019
- 4.2.Strategic development
- 4.2.1.Acquisitions & mergers
- 4.2.2.New Product launches
- 4.2.3.Agreements, partnerships, cullaborations, and joint ventures
- 4.2.4.Research and development and Regional expansion
- 4.3.Price trend analysis
- 4.1.Company market share analysis
- Chapter 5.Global Animal Drug CompoundingMarket– Product Analysis
- 5.1.Global Animal Drug CompoundingMarket overview: By Product
- 5.1.1.Global Animal Drug CompoundingMarket share, By Product, 2020 and 2028
- 5.2.Anti-Infectives
- 5.2.1.Global Animal Drug CompoundingMarket by Anti-Infectives, 2018–2028(USD Billion)
- 5.3.Anti-Inflammatory
- 5.3.1.Global Animal Drug CompoundingMarket by Anti-Inflammatory, 2018–2028(USD Billion)
- 5.4.GI Drugs
- 5.4.1.Global Animal Drug CompoundingMarket by GI Drugs, 2018–2028(USD Billion)
- 5.5.CNS Agents
- 5.5.1.Global Animal Drug CompoundingMarket by CNS Agents, 2018–2028(USD Billion)
- 5.1.Global Animal Drug CompoundingMarket overview: By Product
- Chapter 6.Global Animal Drug CompoundingMarket– Animal Type Analysis
- 6.1.Global Animal Drug CompoundingMarket overview: By Animal Type
- 6.1.1.Global Animal Drug CompoundingMarket share, By Animal Type, 2020 and 2028
- 6.2.Companion Animal
- 6.2.1.Global Animal Drug CompoundingMarket by Companion Animal , 2018–2028(USD Billion)
- 6.3.Livestock Animal
- 6.3.1.Global Animal Drug CompoundingMarket by Livestock Animal, 2018–2028(USD Billion)
- 6.1.Global Animal Drug CompoundingMarket overview: By Animal Type
- Chapter 7.Global Animal Drug CompoundingMarket– Route of Administration Analysis
- 7.1.Global Animal Drug CompoundingMarket overview: By Route of Administration
- 7.1.1.Global Animal Drug CompoundingMarket share, By Route of Administration, 2020 and 2028
- 7.2.Oral
- 7.2.1.Global Animal Drug CompoundingMarket by Oral , 2018–2028(USD Billion)
- 7.3.Injectables
- 7.3.1.Global Animal Drug CompoundingMarket by Injectables, 2018–2028(USD Billion)
- 7.4.Ocular
- 7.4.1.Global Animal Drug CompoundingMarket by Ocular, 2018–2028(USD Billion)
- 7.5.Topical
- 7.5.1.Global Animal Drug CompoundingMarket by Topical, 2018–2028(USD Billion)
- 7.6.Rectal
- 7.6.1.Global Animal Drug CompoundingMarket by Rectal, 2018–2028(USD Billion)
- 7.1.Global Animal Drug CompoundingMarket overview: By Route of Administration
- Chapter 8.Global Animal Drug CompoundingMarket overview: By Dosage Form
- 8.1.Global Animal Drug CompoundingMarket share, By Dosage Form, 2020 and 2028
- 8.2.Capsule
- 8.2.1.Global Animal Drug CompoundingMarket by Capsule , 2018–2028(USD Billion)
- 8.3.Powder
- 8.3.1.Global Animal Drug CompoundingMarket by Powder, 2018–2028(USD Billion)
- 8.4.Sulution
- 8.4.1.Global Animal Drug CompoundingMarket by Sulution, 2018–2028(USD Billion)
- 8.5.Suspension
- 8.5.1.Global Animal Drug CompoundingMarket by Suspension, 2018–2028(USD Billion)
- Chapter 9.Company Profiles
- 9.1.Wedgewood Pharmacy
- 9.1.1.Overview
- 9.1.2.Financials
- 9.1.3.Product Portfolio
- 9.1.4.Business Strategy
- 9.1.5.Recent Developments
- 9.2.Davis Islands Pharmacy
- 9.2.1.Overview
- 9.2.2.Financials
- 9.2.3.Product Portfolio
- 9.2.4.Business Strategy
- 9.2.5.Recent Developments
- 9.3.Millers Pharmacy
- 9.3.1.Overview
- 9.3.2.Financials
- 9.3.3.Product Portfolio
- 9.3.4.Business Strategy
- 9.3.5.Recent Development
- 9.4.Wellness Pharmacy of Cary
- 9.4.1.Overview
- 9.4.2.Financials
- 9.4.3.Product Portfolio
- 9.4.4.Business Strategy
- 9.4.5.Recent Development
- 9.5.Smith’s Pharmacy
- 9.5.1. Overview
- 9.5.2.Financials
- 9.5.3.Product Portfolio
- 9.5.4.Business Strategy
- 9.5.5.Recent Development
- 9.6.Central Compounding Center South
- 9.6.1.Overview
- 9.6.2.Financials
- 9.6.3. Product Portfolio
- 9.6.4.Business Strategy
- 9.6.5.Recent Development
- 9.7.Caringbah Compounding Pharmacy
- 9.7.1.Overview
- 9.7.2.Financials
- 9.7.3.Product Portfolio
- 9.7.4.Business Strategy
- 9.7.5.Recent Development
- 9.8.Triangle Compounding Pharmacy
- 9.8.1. Overview
- 9.8.2.Financials
- 9.8.3.Product Portfolio
- 9.8.4.Business Strategy
- 9.8.5.Recent Development
- 9.1.Wedgewood Pharmacy
Table Of Figures
List of Figures
1.Market research Type
2.Market research methodology
3.Global Animal Drug CompoundingMarket, 2018–2028(USD Billion)
4.Porter’s Five Forces Analysis
5.Global Animal Drug CompoundingMarketattractiveness, By Product
6.Global Animal Drug CompoundingMarketattractiveness, By Route of Administration
7.Global Animal Drug CompoundingMarketattractiveness, By Animal Type
8.Global Animal Drug CompoundingMarketattractiveness, By Dosage Form
9.Global Animal Drug CompoundingMarketshare by Product ,2020 and 2028 (USD Billion)
10.Global Animal Drug CompoundingMarketby Anti-Infectives, 2018–2028(USD Billion)
11.Global Animal Drug CompoundingMarketby Anti-Inflammatory, 2018–2028(USD Billion)
12.Global Animal Drug CompoundingMarketby GI Drugs, 2018–2028(USD Billion)
13.Global Animal Drug CompoundingMarketby CNS Agents, 2018–2028(USD Billion)
14.Global Animal Drug CompoundingMarketshare by Animal Type ,2020 and 2028 (USD Billion)
15.Global Animal Drug CompoundingMarketby Companion Animal , 2018–2028(USD Billion)
16.Global Animal Drug CompoundingMarketby Livestock Animal, 2018–2028(USD Billion)
17.Global Animal Drug CompoundingMarketshare by Route of Administration ,2020 and 2028 (USD Billion)
18.Global Animal Drug CompoundingMarketby Oral, 2018–2028(USD Billion)
19.Global Animal Drug CompoundingMarketby Injectables, 2018–2028(USD Billion)
20.Global Animal Drug CompoundingMarketby Ocular, 2018–2028(USD Billion)
21.Global Animal Drug CompoundingMarketby Topical, 2018–2028(USD Billion)
22.Global Animal Drug CompoundingMarketby Rectal, , 2018–2028(USD Billion)
23.Global Animal Drug CompoundingMarketshare by Route of Administration ,2020 and 2028 (USD Billion)
24.Global Animal Drug CompoundingMarketby Capsule, 2018–2028(USD Billion)
25.Global Animal Drug CompoundingMarketby Solution, 2018–2028(USD Billion)
26.Global Animal Drug CompoundingMarketby Suspension, 2018–2028(USD Billion)
27.Global Animal Drug CompoundingMarketby Powder, 2018–2028(USD Billion)
28.Global Animal Drug CompoundingMarketshare, by Region, 2020 and 2028
29.North America Animal Drug CompoundingMarket, 2018–2028(USD Billion)
30.Europe Animal Drug CompoundingMarket, 2018–2028(USD Billion)
31.Asia Pacific Animal Drug CompoundingMarket, 2018–2028(USD Billion)
32.Latin America Animal Drug CompoundingMarket, 2018–2028(USD Billion)
33.The Middle East and Africa Animal Drug CompoundingMarket, 2018–2028(USD Billion)
Table Of Tables
List of Tables
1.Global Animal Drug CompoundingMarket: snapshot
2.Drivers of the Animal Drug CompoundingMarket: impact analysis
3.North America Animal Drug CompoundingMarket revenue, By Product ,2018–2028(USD Billion)
4.North America Animal Drug CompoundingMarket revenue, By Animal Type ,2018–2028(USD Billion)
5.North America Animal Drug CompoundingMarket revenue, By Route of Administration ,2018–2028(USD Billion)
6.North America Animal Drug CompoundingMarket revenue, By Dosage Form ,2018–2028(USD Billion)
7.The U.S. Animal Drug CompoundingMarket revenue, By Product ,2018–2028(USD Billion)
8.The U.S. Animal Drug CompoundingMarket revenue, By Animal Type ,2018–2028(USD Billion)
9.The U.S. Animal Drug CompoundingMarket revenue, By Route of Administration ,2018–2028(USD Billion)
10.The U.S. Animal Drug CompoundingMarket revenue, By Dosage Form ,2018–2028(USD Billion)
11.Rest of North America Animal Drug CompoundingMarket revenue, By Product ,2018–2028(USD Billion)
12.Rest of North America Animal Drug CompoundingMarket revenue, By Animal Type ,2018–2028(USD Billion)
13.Rest of North America Animal Drug CompoundingMarket revenue, By Route of Administration ,2018–2028(USD Billion)
14.Rest of North America Animal Drug CompoundingMarket revenue, By Dosage Form ,2018–2028(USD Billion)
15.Europe Animal Drug CompoundingMarket revenue, By Product ,2018–2028(USD Billion)
16.Europe Animal Drug CompoundingMarket revenue, By Animal Type ,2018–2028(USD Billion)
17.Europe Animal Drug CompoundingMarket revenue, By Route of Administration ,2018–2028(USD Billion)
18.Europe Animal Drug CompoundingMarket revenue, By Dosage Form ,2018–2028(USD Billion)
19.UK Animal Drug CompoundingMarket revenue, By Product ,2018–2028(USD Billion)
20.UK Animal Drug CompoundingMarket revenue, By Animal Type ,2018–2028(USD Billion)
21.UK Animal Drug CompoundingMarket revenue, By Route of Administration ,2018–2028(USD Billion)
22.UK Animal Drug CompoundingMarket revenue, By Dosage Form ,2018–2028(USD Billion)
23.France Animal Drug CompoundingMarket revenue, By Product ,2018–2028(USD Billion)
24.France Animal Drug CompoundingMarket revenue, By Animal Type ,2018–2028(USD Billion)
25.France Animal Drug CompoundingMarket revenue, By Route of Administration ,2018–2028(USD Billion)
26.France Animal Drug CompoundingMarket revenue, By Dosage Form ,2018–2028(USD Billion)
27.Germany Animal Drug CompoundingMarket revenue, By Product ,2018–2028(USD Billion)
28.Germany Animal Drug CompoundingMarket revenue, By Animal Type ,2018–2028(USD Billion)
29.Germany Animal Drug CompoundingMarket revenue, By Route of Administration ,2018–2028(USD Billion)
30.Germany Animal Drug CompoundingMarket revenue, By Dosage Form ,2018–2028(USD Billion)
31.Rest of Europe Animal Drug CompoundingMarket revenue, By Product ,2018–2028(USD Billion)
32.Rest of Europe Animal Drug CompoundingMarket revenue, By Animal Type ,2018–2028(USD Billion)
33.Rest of Europe Animal Drug CompoundingMarket revenue, By Route of Administration ,2018–2028(USD Billion)
34.Rest of Europe Animal Drug CompoundingMarket revenue, By Dosage Form ,2018–2028(USD Billion)
35.Asia Pacific Animal Drug CompoundingMarket revenue, By Product ,2018–2028(USD Billion)
36.Asia Pacific Animal Drug CompoundingMarket revenue, By Animal Type ,2018–2028(USD Billion)
37.Asia Pacific Animal Drug CompoundingMarket revenue, By Route of Administration ,2018–2028(USD Billion)
38.Asia Pacific Animal Drug CompoundingMarket revenue, By Dosage Form ,2018–2028(USD Billion)
39.China Animal Drug CompoundingMarket revenue, By Product ,2018–2028(USD Billion)
40.China Animal Drug CompoundingMarket revenue, By Animal Type ,2018–2028(USD Billion)
41.China Animal Drug CompoundingMarket revenue, By Route of Administration ,2018–2028(USD Billion)
42.China Animal Drug CompoundingMarket revenue, By Dosage Form ,2018–2028(USD Billion)
43.Japan Animal Drug CompoundingMarket revenue, By Product ,2018–2028(USD Billion)
44.Japan Animal Drug CompoundingMarket revenue, By Animal Type ,2018–2028(USD Billion)
45.Japan Animal Drug CompoundingMarket revenue, By Route of Administration ,2018–2028(USD Billion)
46.Japan Animal Drug CompoundingMarket revenue, By Dosage Form ,2018–2028(USD Billion)
47.India Animal Drug CompoundingMarket revenue, By Product ,2018–2028(USD Billion)
48.India Animal Drug CompoundingMarket revenue, By Animal Type ,2018–2028(USD Billion)
49.India Animal Drug CompoundingMarket revenue, By Route of Administration ,2018–2028(USD Billion)
50.India Animal Drug CompoundingMarket revenue, By Dosage Form ,2018–2028(USD Billion)
51.Rest of Asia Pacific Animal Drug CompoundingMarket revenue, By Product ,2018–2028(USD Billion)
52.Rest of Asia Pacific Animal Drug CompoundingMarket revenue, By Animal Type ,2018–2028(USD Billion)
53.Rest of Asia Pacific Animal Drug CompoundingMarket revenue, By Route of Administration ,2018–2028(USD Billion)
54.Rest of Asia Pacific Animal Drug CompoundingMarket revenue, By Dosage Form ,2018–2028(USD Billion)
55.Latin America Animal Drug CompoundingMarket revenue, By Product ,2018–2028(USD Billion)
56.Latin America Animal Drug CompoundingMarket revenue, By Animal Type ,2018–2028(USD Billion)
57.Latin America Animal Drug CompoundingMarket revenue, By Route of Administration ,2018–2028(USD Billion)
58.Latin America Animal Drug CompoundingMarket revenue, By Dosage Form ,2018–2028(USD Billion)
59.Brazil Animal Drug CompoundingMarket revenue, By Product ,2018–2028(USD Billion)
60.Brazil Animal Drug CompoundingMarket revenue, By Animal Type ,2018–2028(USD Billion)
61.Brazil Animal Drug CompoundingMarket revenue, By Route of Administration ,2018–2028(USD Billion)
62.Brazil Animal Drug CompoundingMarket revenue, By Dosage Form ,2018–2028(USD Billion)
63.Rest of Latin America Animal Drug CompoundingMarket revenue, By Product ,2018–2028(USD Billion)
64.Rest of Latin America Animal Drug CompoundingMarket revenue, By Animal Type ,2018–2028(USD Billion)
65.Rest of Latin America Animal Drug CompoundingMarket revenue, By Route of Administration ,2018–2028(USD Billion)
66.Rest of Latin America Animal Drug CompoundingMarket revenue, By Dosage Form ,2018–2028(USD Billion)
67.The Middle East and Africa Animal Drug CompoundingMarket revenue, By Product ,2018–2028(USD Billion)
68.The Middle East and Africa Animal Drug CompoundingMarket revenue, By Animal Type ,2018–2028(USD Billion)
69.The Middle East and Africa Animal Drug CompoundingMarket revenue, By Route of Administration ,2018–2028(USD Billion)
70.The Middle East and Africa Animal Drug CompoundingMarket revenue, By Dosage Form ,2018–2028(USD Billion)
71.Saudi Arabia Animal Drug CompoundingMarket revenue, By Product ,2018–2028(USD Billion)
72.Saudi Arabia Animal Drug CompoundingMarket revenue, By Animal Type ,2018–2028(USD Billion)
73.Saudi Arabia Animal Drug CompoundingMarket revenue, By Route of Administration ,2018–2028(USD Billion)
74.Saudi Arabia Animal Drug CompoundingMarket revenue, By Dosage Form ,2018–2028(USD Billion)
75.South Africa Animal Drug CompoundingMarket revenue, By Product ,2018–2028(USD Billion)
76.South Africa Animal Drug CompoundingMarket revenue, By Animal Type ,2018–2028(USD Billion)
77.South Africa Animal Drug CompoundingMarket revenue, By Route of Administration ,2018–2028(USD Billion)
78.South Africa Animal Drug CompoundingMarket revenue, By Dosage Form ,2018–2028(USD Billion)
79.Rest of the Middle East & Africa Animal Drug CompoundingMarket revenue, By Product ,2018–2028(USD Billion)
80.Rest of the Middle East & Africa Animal Drug CompoundingMarket revenue, By Animal Type ,2018–2028(USD Billion)
81.Rest of the Middle East & Africa Animal Drug CompoundingMarket revenue, By Route of Administration ,2018–2028(USD Billion)
82.Rest of the Middle East & Africa Animal Drug CompoundingMarket revenue, By Dosage Form ,2018–2028(USD Billion)
Methodology
FrequentlyAsked Questions
Animal drug compounding customizes medications for animals. It adjusts dosage and formulation for specific needs
The global Animal Drug Compounding market is expected to be driven by the demand for customized veterinary medications. Rising pet ownership and livestock healthcare needs boost market expansion.
According to study, the global Animal Drug Compounding market size was worth around USD 2.63 Billion in 2023 and is predicted to grow to around USD 5.82 Billion By 2032.
The global Animal Drug Compounding market is expected to grow at a Compound Annual Growth Rate (CAGR) of around CAGR 9.2% during the forecast period from 2024-2032.
The global Animal Drug Compounding industry is projected to be challenged by Challenges include regulatory oversight, dosage accuracy, and quality consistency.
The Opportunities include veterinary care growth, personalized animal treatments, companion animal healthcare demand, and specialty pharmacies will offer significant growth opportunities in the Animal Drug Compounding market.
Customized dosing and formulations; regulatory-compliant sterile compounding; demand from veterinary specialty care are the emerging trends and innovations impacting the Animal Drug Compounding market.
The global Animal Drug Compounding market is expected to be led by North America during the forecast period.
Some of the prominent players operating in the global Animal Drug Compounding market are; Wedgewood Pharmacy, Davis Islands Pharmacy, Millers Pharmacy, Wellness Pharmacy of Cary, Smith’s Pharmacy, Central Compounding Center South, Caringbah Compounding Pharmacy, and Triangle Compounding Pharmacy and others.
The report explores crucial aspects of the Animal Drug Compounding market, including a detailed discussion of existing growth factors and restraints, while also browsing future growth opportunities and challenges that impact the market.
HappyClients
